iRhythm Technologies Inc IRTC Fundamentals and Key Ratios

iRhythm Technologies Inc. (IRTC) Fundamentals


iRhythm Technologies Inc is a commercial-stage digital healthcare company redefining the way cardiac arrhythmias are clinically diagnosed by combining wearable biosensing technology with cloud-based data analytics and machine-learning capabilities. The company's portfolio include ambulatory cardiac monitoring services on a platform, called the Zio service, which combines an easy-to-wear and unobtrusive biosensor that can be worn for up to 14 consecutive days with powerful proprietary algorithms that distill data from millions of heartbeats into clinically actionable information. The company derived its revenue from the United States.

iRhythm Technologies Inc is a commercial-stage digital healthcare company redefining the way cardiac arrhythmias are clinically diagnosed by combining wearable biosensing technology with cloud-based data analytics and machine-learning capabilities. The company's portfolio include ambulatory cardiac monitoring services on a platform, called the Zio service, which combines an easy-to-wear and unobtrusive biosensor that can be worn for up to 14 consecutive days with powerful proprietary algorithms that distill data from millions of heartbeats into clinically actionable information. The company derived its revenue from the United States.

SHARE INFORMATION
Market Cap	$ 3,290,817,857
Shares Outstanding	30,110,878
Float	26,734,804
Percent Float	88.79%
Short Interest	0.00
Short Percent Float	0.0%
Short Interest Ratio	0.00
Short Interest Date	-
Latest Fiscal Dividend Per Share	$ 0.00
Latest Fiscal Revenue	$ 322,825,000
Latest Fiscal EPS	$ -3.46
Latest Fiscal Date	2021-12-31

DIVIDENDS
Dividend (3 Years)	$ 0.00
Dividend (5 Years)	$ 0.00
Ex Dividend Date	-
Dividend Rate	$ 0.00
Dividend Yield	0.0%
Payment Cash	-

HOLDERS
Institutions	553
Institutional Holdings Date	2023-01-31
Institutional Bought Previous 3 Months	4,003,716
Institutional Holdings Percent	183.3%
Institutional Sold Previous 3 Months	4,031,420
Insider Holdings Date	2023-01-31
Insider Bought Previous 3 Months	28,704
Insider Holdings Percent	2.5
Insider Sold Previous 3 Months	15,403
Insider Shares Owned	743,880

TRADING INFO
52 Week High	$ 169.54
52 Week Low	$ 85.74
52 Week High Change	$ -10.23
21 Day Moving Average	$ 99.46
21 Day Extended Moving Average	$ 100.6243
50 Day Moving Average	$ 99.082
50 Day Extended Moving Average	$ 102.0034
200 Day Moving Average	$ 123.8736
200 Day Extended Moving Average	$ 115.7177
10 Day Average Volume	235,147
20 Day Average Volume	298,627
30 Day Average Volume	275,332
50 Day Average Volume	290,158
Alpha	0.015492
Beta	1.4267
Standard Deviation	0.198936
R2	0.150044
7 Day Price Change	$ 8.98
7 Day Percent Change	8.95%
21 Day Price Change	$ 7.50
21 Day Percent Change	7.37%
30 Day Price Change	$ 15.21
30 Day Percent Change	16.17%
Month to Date Price Change	$ 10.99
Month to Date Percent Change	11.18%
Quarter to Date Price Change	$ 15.62
Quarter to Date Percent Change	16.68%
180 Day Price Change	$ -45.40
180 Day Percent Change	-29.35%
200 Day Price Change	$ -33.02
200 Day Percent Change	-23.2%
Year to Date Price Change	$ 15.62
Year to Date Percent Change	16.68%

PROFITABILITY
EBIT Margin	-32.8%
EBITDA Margin	-29.5%
Pre-Tax Profit Margin	-30.8%
Profit Margin Count	-32.17%
Gross Margin	66.9%
Profit Margin TOT	-32.17%

INCOME STATEMENTS
Revenue	$ 298,304,000
Revenue Per Share	$ 9.9069
Revenue (3 Years)	$ 12.71
Revenue (5 Years)	$ 26.70

FINANCIAL STRENGTH
Price to Tangible Book	13.80
Total Debt To Equity	0.50
Int Coverage	-37.00
Current Ratio	3.40
Leverage Ratio	1.80
Quick Ratio	3.20
Long Term Debt To Capital	0.33

VALUATION MEASURES
PE Ratio	-25.20
Enterprise Value	$ 3,216,611,856
Price to Sales	11.0318
Price to Free Cash	-56.40
PE High Last 5 Years	-14.30
Price To Book	13.80
Price To Cash Flow	0.00
PE Low Last 5 Years	-41.80
Price to Tangible Book	13.80

MANAGEMENT EFFECTIVENESS
Receivables Turnover	2.10
Invoice Turnover	10.20
Assets Turnover	0.30
Return Assets	-27.90
Return on Equity	-48.01
Return on Capital	-32.17

PROFILE INFO
Issue Type	CS
SEC Type	EQS
Auditor	PricewaterhouseCoopers LLP
CEO	Quentin S. Blackford
Emplyoees	1700
Last Audit	UQ
CIK	0001388658
Industry	Medical Devices & Instruments
Sector	Healthcare
NAICS	Surgical and Medical Instrument Manufacturing(339112)

CONTACT INFO
Address	699 8th Street Suite 600 San Francisco, CA 94103
Website	https://www.irhythmtech.com
Facsimile	-
Telephone	+1 415 632-5700
Email	investors@irhythmtech.com

Quotes:

IHub:

IRTC

iRhythm Technologies Inc. (IRTC) Fundamentals

iRhythm Technologies Inc. (IRTC) Key Ratios

iRhythm Technologies Inc. (IRTC) Profile